Friday, 25th January 2013 - 9h00 – 17h00 |
9h00 |
Welcome address
Maria José Sá, Dept. of Neurology, Centro Hospitalar São João, Porto, Health Sciences Faculty, University Fernando Pessoa, Porto |
9h15 – 11h15 |
Session 1 – MS and Neuroimmunology
Chairpersons: to be defined
The cytokines network in MS relapses and the impact of high dose intravenous methylprednisolone
Christian Sindic, Dept. of Neurology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
Autoimmunity and MS
Thomas Berger, Multiple Sclerosis Clinic, Clinical Dept. of Neurology, Innsbruck Medical University, Austria
Update in body fluid markers
Gavin Giovannoni, Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK |
11h15 – 12h00 |
Coffee Break | Exhibition Hall | Poster view |
12h00 – 13h00 |
Conference “Evidence for Disease Heterogeneity in MS: Update on Controversy”
Chairpersons:
Maria José Sá, Dept. of Neurology, Centro Hospitalar São João, Porto, Health Sciences Faculty, University Fernando Pessoa, Porto
Claudia Lucchinetti, Dept. of Neurology, Mayo Clinic College of Medicine, Rochester, USA |
13h00 – 14h30 |
Lunch |
14h30 – 15h00 |
Conference "Tiles of a city: streets and monuments of Oporto"
Chairperson:
Salvato Trigo, Dean of the University Fernando Pessoa
Sérgio Lira, Human and Social Sciences Faculty, University Fernando Pessoa, Porto |
15h00 – 17h00 |
Session 2 – Cognition in Multiple Sclerosis
Chairpersons: to be defined
Assessment of cognition in MS
Stephen Rao, Neurological Institute Cleveland Clinic, USA
Cognitive Dysfunction in MS: problems and solutions
Maria Pia Amato, Dept. of Neurology University of Florence, Italy
Cortical lesions and atrophy in MS
Paolo Gallo, The Multiple Sclerosis Centre of Veneto Region, Dept of Neurosciences, University Hospital, Padova, Veneto, Italy |
17h00 – 17h30 |
Coffee Break | Exhibition Hall | Poster view |
17h30 – 19h00 |
Short-Courses (90’)
- MS and Autoimmune diseases
- MS escalating therapy
- MS Team – focus in MS nurses |
20h00 |
Gala Dinner |
Saturday, 26th January 2013 - 9h00 – 17h00 |
9h00 – 10h30 |
Session 3 – Centred-patient Therapy
Chairpersons: to be defined
Treatment “a la carte”: reality or fiction?
Oscar Fernandez, Hospital Regional Universitario Carlos Haya, Malaga, Spain
Overview of rehabilitation approaches
Jurg Kesselring, Dept. of Neurology and Neurorehabilitation, Rehabilitation Centre, Valens, Switzerland |
10h30 – 11h00 |
Coffee Break | Exhibition Hall | Poster view |
11h00 – 12h00 |
Conference “2012 Hot Topics in MS”
Chairperson: to be defined
Otto Hommes, European Charcot Foundation Molenhoek, Netherlands
Joint Meeting with Multiple Sclerosis Study Group of Portuguese Society of Neurology
“Grupo de Estudos de Esclerose Múltipla (GEEM)” |
12h00 |
Welcome address
Joaquim Pinheiro, Dept. of Neurology, Centro Hospitalar Vila Nova Gaia/Espinho |
12h15–13h30 |
Session 4 – Ten minutes vignettes of approved disease-modifying drugs
Chairpersons: to be defined
Avonex ® (Biogen Idec)
Betaferon® (Bayer Healthcare)
Copaxone® (Teva)
Gylenia ® (Novartis Pharma)
Rebif® (Merck Serono)
Tysabri ® (Biogen Idec) |
13h30 – 14h30 |
Lunch |
14h30 – 15h30 |
Poster session
Chairpersons: to be defined |
15h30 – 17h00 |
Oral presentations
Chairpersons: to be defined |
17h00 – 17h30 |
Coffee Break | Exhibition Hall |
17h30 |
City Tour |
20h00 |
Dinner |
PDF
Version available here for download...
|